Financhill
Back

Geron Corp. 10K Form

Sell
50

GERN
Geron Corp.

Last Price:
$1.27
Seasonality Move:
17.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive GERN News And Ratings

See the #1 stock for the next 7 days that we like better than GERN

GERN Financial Statistics

Sales & Book Value

Annual Sales: $77M
Cash Flow: $-13.5M
Price / Cash Flow: 0
Annual Sales: $0.39
Price / Book: 3.26

Profitability

EPS (TTM): -0.12020
Net Income (TTM): $-80M
Gross Margin: $75.7M
Return on Equity: -29.65%
Return on Assets: -14.68%

Geron Corp. Earnings Forecast

Key Geron Corp. Financial Ratios

  • The Gross Profit Margin over the past 29 years for GERN is 98.37%.
  • The Selling, General & Administrative Expenses for GERN have been equal to 189.28% of Gross Profit Margin.
  • The Research & Development expenses have been 134.74% of Revenue.
  • The Net Earning history of GERN is -226.73% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Geron Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GERN
CUSIP: 374163
Website: geron.com

Debt

Debt-to-Equity Ratio: 1.01
Current Ratio: 5.96
Quick Ratio: 4.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 45.53

GERN Technical Analysis vs Fundamental Analysis

Sell
50
Geron Corp. (GERN) is a Sell

Is Geron Corp. a Buy or a Sell?

  • Geron Corp. stock is rated a Sell
    The current Geron Corp. [GERN] share price is $1.27. The Score for GERN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.